Winnow Wealth’s Edwards Lifesciences EW Stock Holding History

Winnow Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21	Closed	-$1.81K	–	271
2025 Q4	$1.81K	Buy	21 +2	+11%	+$164	﹤0.01%	370
2025 Q3	$1.48K	Buy	+19	New	+$1.49K	﹤0.01%	379
2025 Q2	–	Sell	-19	Closed	-$1.34K	–	346
2025 Q1	$1.34K	Buy	19 +6	+46%	+$429	﹤0.01%	352
2024 Q4	$929	Buy	+13	New	+$910	﹤0.01%	346

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Winnow Wealth's EW Position: Q1 2026 in Review

Winnow Wealth sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 21 shares — an estimated $1.81K sold.

Winnow Wealth first reported a position in EW in Q4 2024 and held it in 4 quarters. The position peaked at $1.81K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Winnow Wealth reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
Winnow Wealth sold 21 Edwards Lifesciences shares in Q1 2026, an estimated $1.81K.
Winnow Wealth first reported a position in Edwards Lifesciences in Q4 2024 and held it in 4 quarters.
Winnow Wealth's Edwards Lifesciences position peaked at $1.81K in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Winnow Wealth's 13F filing for Q1 2026, filed 19 May 2026.